LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
- 31 October 2010
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 40 (1), 73-81
- https://doi.org/10.1016/j.nbd.2010.04.002
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on DimerizationPublished by Elsevier BV ,2009
- Homo‐ and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragmentJournal of Neurochemistry, 2009
- R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in miceProceedings of the National Academy of Sciences, 2009
- LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegansJournal of Neuroscience, 2009
- Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite OutgrowthJournal of Biological Chemistry, 2009
- Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three QuestionsASN Neuro, 2009
- Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's diseaseJournal of Neuroscience Research, 2008
- An imaging system for standardized quantitative analysis of C. elegans behaviorBMC Bioinformatics, 2004
- Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegansProceedings of the National Academy of Sciences, 2002
- C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic PathwayNeuron, 2000